Galcanezumab effectiveness on comorbid cluster headache and chronic migraine: a prospective case series

被引:0
作者
Luigi Francesco Iannone
Davide Fattori
Pierangelo Geppetti
Francesco De Cesaris
机构
[1] Careggi University Hospital,Headache Center and Clinical Pharmacology Unit
[2] University of Florence,Section of Clinical Pharmacology and Oncology, Department of Health Sciences
来源
Neurological Sciences | 2022年 / 43卷
关键词
Calcitonin gene-related peptide; Cluster headache; Migraine; Galcanezumab;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:697 / 703
页数:6
相关论文
共 131 条
[1]  
Vollesen AL(2018)Migraine and cluster headache—the common link J Headache Pain 19 89-1876
[2]  
Benemei S(2020)Migraine N Engl J Med 383 1866-83
[3]  
Cortese F(2011)Chronic migraine, classification, differential diagnosis, and epidemiology Headache 51 Suppl 2 77-83
[4]  
Labastida-Ramirez A(2018)Diagnosis, pathophysiology, and management of cluster headache Lancet Neurol 17 75-25
[5]  
Marchese F(2018)Cluster headache Nat Rev Dis Primers 4 18006-764
[6]  
Pellesi L(1996)Coexistence of migraine and cluster headache: report of 10 cases and possible pathogenetic implications Headache 37 21-123
[7]  
Romoli M(2016)Evaluation of guideline-adherent treatment in cluster headache Cephalalgia 36 760-187
[8]  
Ashina M(1995)Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack Pain 60 119-1197
[9]  
Lampl C(1990)Vasoactive peptide release in the extracerebral circulation of humans during migraine headache Ann Neurol 28 183-141
[10]  
Ashina M(2018)Effect of infusion of calcitonin gene-related peptide on cluster headache attacks: a randomized clinical trial JAMA Neurol 75 1187-389